Evaluation of the Effect of Root Canal Preparation by TF and M-Pro on Post-Operative Pain After Single Visit Endodontic Treatment
Launched by CAIRO UNIVERSITY · Jan 20, 2018
Trial Information
Current as of May 27, 2025
Completed
Keywords
ClinConnect Summary
Teeth with symptomatic irreversible pulpitis are selected according to the eligibility and exclusion criteria and patients are then randomized to receive treatment after using Twisted files or M-pro files. The treatment is done in single visit. The postoperative pain is then assessed using the Numerical Rating Scale 6,12, 24 and 48 hours post-instrumentation.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients in good health (American Society of Anesthesiologists Class II or higher).
- • Patients having symptomatic irreversible pulpitis in their single rooted teeth.
- • Age range is between 20 and 60 years.
- • Patients who can understand numerical rating scale (NRS).
- • Patients able to sign informed consent.
- Exclusion Criteria:
- • Patients with positive percussion test.
- • Patients having history of necrosis with or without apical pathosis.
- • Patients have sinus tract or fistula extra oral or intraoral.
- • Pregnant or mentally retarded patients.
- • Teeth with grade 2 or 3 mobility.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials